Northwest Investment Counselors LLC lowered its position in Colgate-Palmolive (NYSE:CL) by 1.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 29,967 shares of the company’s stock after selling 504 shares during the period. Northwest Investment Counselors LLC’s holdings in Colgate-Palmolive were worth $2,362,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of CL. Wolff Wiese Magana LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth about $25,000. Grant Street Asset Management Inc. bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $28,000. TRU Independence Asset Management 2 LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $29,000. Encompass Wealth Advisors LLC acquired a new position in Colgate-Palmolive in the 4th quarter worth about $29,000. Finally, Accel Wealth Management acquired a new position in Colgate-Palmolive in the 4th quarter worth about $33,000. 76.47% of the stock is owned by institutional investors.
In other Colgate-Palmolive news, insider Jennifer Daniels sold 20,692 shares of the company’s stock in a transaction on Thursday, February 4th. The stock was sold at an average price of $78.65, for a total value of $1,627,425.80. Following the completion of the sale, the insider now directly owns 55,585 shares in the company, valued at approximately $4,371,760.25. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Philip G. Shotts sold 346 shares of the firm’s stock in a transaction on Tuesday, February 16th. The stock was sold at an average price of $77.16, for a total value of $26,697.36. Following the completion of the sale, the vice president now directly owns 41,128 shares of the company’s stock, valued at $3,173,436.48. The disclosure for this sale can be found here. Insiders sold 30,810 shares of company stock worth $2,418,650 over the last ninety days. Corporate insiders own 0.78% of the company’s stock.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Thursday, January 28th. The company reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.76 by $0.01. Colgate-Palmolive had a return on equity of 383.88% and a net margin of 16.65%. The company had revenue of $4.32 billion during the quarter, compared to analysts’ expectations of $4.15 billion. During the same quarter in the prior year, the firm posted $0.73 EPS. Colgate-Palmolive’s quarterly revenue was up 7.7% compared to the same quarter last year. On average, equities research analysts predict that Colgate-Palmolive will post 3.05 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 14th. Investors of record on Wednesday, April 21st will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.22%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.44. The ex-dividend date is Tuesday, April 20th. Colgate-Palmolive’s payout ratio is presently 62.19%.
Several equities research analysts have recently weighed in on the company. Royal Bank of Canada cut Colgate-Palmolive from an “outperform” rating to a “sector perform” rating and set a $90.00 price target for the company. in a research note on Monday, January 4th. Credit Suisse Group upgraded Colgate-Palmolive from an “underperform” rating to a “neutral” rating and increased their price target for the stock from $70.00 to $80.00 in a report on Monday, February 1st. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $87.00 to $85.00 and set a “neutral” rating on the stock in a report on Thursday. Sanford C. Bernstein initiated coverage on Colgate-Palmolive in a research report on Tuesday, January 19th. They issued an “underperform” rating and a $77.00 target price for the company. Finally, Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $83.00 target price for the company. in a research note on Thursday, January 28th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $82.17.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.
Recommended Story: What is the Dividend Aristocrat Index?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.